George Somlo MD
Breast Cancer, Hematologic Oncology
Professor, Departments of Medical Oncology&Therapeutics Research and Hematology and Hematopoietic Cell Transplantation
Join to view full profile
1601 Island View DrSeal Beach, CA 90740
Phone+1 562-596-6038
Dr. Somlo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1987
University of California (Irvine)Residency, Internal Medicine, 1983 - 1985
Semmelweis UniversityClass of 1978
Certifications & Licensure
CA State Medical License 1983 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2013-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Acute Care, Allscripts, 2013-2017
- CMS Meaningful Use Stage 2 Certification Allscripts FollowMyHealth, Allscripts, 2013-2017
Clinical Trials
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
- High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
- Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer Start of enrollment: 1997 May 30
Publications & Presentations
PubMed
- 1 citationsIntegration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer.Frederick M Howard, James Dolezal, Hanna Hieromnimon, Sara Venters, Sara Kochanny
Medrxiv. 2025-08-27 - 2 citationsUrine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702.Rahul Banerjee, Amber R Fritz, Othman S Akhtar, Ciara L Freeman, Andrew J Cowan
Leukemia. 2025-04-01 - 3 citationsPrognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets.Brooke M Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, Adam D Pfefferle, Michele C Hayward
NPJ Breast Cancer. 2025-03-08
Journal Articles
- ERα-Mediated Cell Cycle Progression Is an Important Requisite for CDK4/6 Inhibitor Response in HR+ Breast CancerJoanne Mortimer, Laura Kruper, Raju Pillai, George Somlo, Yuan Yuan, Oncotarget
Press Mentions
Late-Breaking Abstracts SessionDecember 6th, 2016
Advances in Multiple MyelomaOctober 3rd, 2016
Cancer MoonShot 2020 Announces Breast Cancer Working Group with Multiple Leading Cancer Centers and the Launch of GPS Cancer at ASCO 2016June 7th, 2016
Committees
- Member, 2015 Update Committee, American Society of Clinical Oncology (ASCO) 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
